Valuation: Acarix AB

Market Cap 301M 30.99M 27.22M 25.23M 23.21M 43.87M 2.96B 44.81M 118M 1.45B 116M 114M 5.07B P/E 2026 *
-
P/E 2027 * -
Enterprise Value 301M 30.99M 27.22M 25.23M 23.21M 43.87M 2.96B 44.81M 118M 1.45B 116M 114M 5.07B EV / Sales 2026 *
15.8x
EV / Sales 2027 * 4.33x
Free-Float
80.16%
Yield 2026 *
-
Yield 2027 * -
1 day-0.20%
1 week-0.78%
Current month-0.39%
1 month-0.98%
3 months-13.92%
6 months+0.60%
Current year-5.41%
1 week 0.24
Extreme 0.2435
0.26
1 month 0.24
Extreme 0.242
0.27
Current year 0.22
Extreme 0.2245
0.33
1 year 0.22
Extreme 0.2245
0.47
3 years 0.17
Extreme 0.1688
0.6
5 years 0.17
Extreme 0.1688
1.87
10 years 0.17
Extreme 0.1688
26.8
Manager TitleAgeSince
Chief Executive Officer - 01/02/2024
Chief Executive Officer 62 23/02/2018
Director TitleAgeSince
Director/Board Member 61 01/01/2020
Director/Board Member 52 14/05/2024
Director/Board Member - 14/05/2024
Change 5-day change 1-year change 3-year change Capi.($)
-0.20%-0.78%-35.98%-55.99% 31.29M
+3.10%+10.11%+13.15%-20.54% 17.28B
-2.03%-7.63%+11.71%+93.03% 1.68B
-2.08%-1.97%-41.03%-79.50% 1.25B
+0.40%-6.35%-32.01%+28.29% 1.06B
-1.70%-3.89%-30.46%-54.61% 626M
-0.21%-4.95%-39.99%-56.10% 555M
-2.26%+1.79%+32.19%-53.37% 466M
+1.60%+1.12%-54.14%-59.10% 380M
0.00%-5.46%-24.37%-26.23% 342M
Average -0.34%-0.19%-20.09%-28.41% 2.37B
Weighted average by Cap. +1.96%+4.66%+4.46%-16.51%

Financials

2026 *2027 *
Net sales 19.1M 1.97M 1.73M 1.6M 1.47M 2.78M 188M 2.84M 7.48M 92.3M 7.38M 7.22M 322M 69.5M 7.16M 6.28M 5.83M 5.36M 10.13M 684M 10.34M 27.2M 336M 26.86M 26.28M 1.17B
Net income -28.9M -2.98M -2.61M -2.42M -2.23M -4.21M -285M -4.3M -11.31M -140M -11.17M -10.93M -487M 2.4M 247K 217K 201K 185K 350K 23.63M 357K 939K 11.6M 927K 908K 40.45M
Net Debt - -
Logo Acarix AB
Acarix AB is a Sweden-based provider of diagnostic solutions for coronary artery disease (CAD). The Company’s primary product CADScor System features phonocardiography technique and algorithms. The CADScor System is fixed with a specific patch to the chest of the patient, with the recording head placed at the forth left intercostal space, and the sensor resting on the sternum. Instructions for the procedure are given on the display for the operator and audio cues guide a patient during the two-minute heart sound recording. After recording, the CAD-score is calculated, and presented on the display of the CADScor Sensor, enabling a physicians, nurses and laboratory technicians to make a rule-out diagnosis.
Employees
8
Date Price Change Volume
13/07/26 SEK 0.2535 -0.20% 142,079
10/07/26 SEK 0.2540 -1.17% 80,519
09/07/26 SEK 0.2570 +0.39% 770,882
08/07/26 SEK 0.2560 +2.40% 838,207
07/07/26 SEK 0.2500 -2.34% 1,026,959

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. ACARIX Stock